U.S. pharma giant copyright scrapped two experimental weight loss pills final 12 months—a at the time-day-to-day capsule, lotiglipron, due to elevated liver enzymes and a twice-everyday pill, danuglipron, on account of sturdy Unwanted side effects—but CEO Albert Bourla has explained